window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 13, 2025

  • News
  • About Us
Contact Us

innovation

  • Biologics & Biosimilars,Cell & Gene Therapy

    Cherwell introduces Redipor TwistLock plate range to aid microbial environmental monitoring

    Cleanroom microbiology expert Cherwell, an Analytichem company, has launched a [...]

    June 17, 2025
  • CDMOs & Manufacturing,Partnerships & Funding

    Chrysalis launches following cleanroom asset acquisition and strategic investment

    Chrysalis, a GMP-compliant space and service provider, has formally launched [...]

    June 16, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Partnerships & Funding

    Ethris signs strategic collaboration with Thermo Fisher Scientific to provide access to mRNA technology platforms

    Partnership further validates Ethris’ novel technology platform based on stabilized [...]

    June 16, 2025
  • Cell & Gene Therapy

    Cycuria Therapeutics launches with advisory board and major grant funding

    April 28, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Cereno taps global CRO for next big step in pulmonary hypertension drug trial
    Categories: Clinical Trials, Drug Development, Rare Diseases
  • Eleva doses first volunteers with new therapy targeting rare kidney disease
    Categories: Biologics & Biosimilars, Clinical Trials, Drug Development, Rare Diseases
  • First-in-class cell therapy for rare mitochondrial disorder gains FDA fast track
    Categories: Cell & Gene Therapy, Clinical Trials, Rare Diseases, Regulatory Affairs
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top